4//SEC Filing
Endo International plc 4
Accession 0001209191-14-016943
CIK 0001593034operating
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 7:28 PM ET
Size
20.0 KB
Accession
0001209191-14-016943
Insider Transaction Report
Form 4
Spengler William
Director
Transactions
- Award
Ordinary Shares
2014-02-28+62,662→ 62,662 total - Award
2007 Stock Incentive Plan Stock Options (NQ)
2014-02-28+8,094→ 8,094 totalExercise: $23.82Exp: 2020-03-12→ Ordinary Shares (8,094 underlying) - Award
2010 Stock Incentive Plan Restricted Stock Units (RSU)
2014-02-28+6,515→ 6,515 total - Award
2004 Stock Incentive Plan Stock Options (NQ)
2014-02-28+5,171→ 5,171 totalExercise: $23.90Exp: 2018-06-26→ Ordinary Shares (5,171 underlying) - Award
2007 Stock Incentive Plan Stock Options (NQ)
2014-02-28+10,384→ 10,384 totalExercise: $16.80Exp: 2019-03-12→ Ordinary Shares (10,384 underlying)
Footnotes (5)
- [F1]On February 28, 2014, Endo Health Solutions, Inc. ("Endo") and Paladin Laboratories Inc. ("Paladin") consummated a transaction under an arrangement agreement pursuant to which each of Endo and Paladin was acquired by a new Irish holding company, Endo International plc ("New Endo"). Under the terms of the arrangement agreement (a) New Endo acquired Paladin pursuant to a plan of arrangement under Canadian law and (b) a newly formed subsidiary of New Endo merged with and into Endo, with Endo as the surviving corporation in the merger (the "Merger") and an indirect wholly owned subsidiary of New Endo. At the effective time of the Merger, each Endo common share was cancelled and converted into the right to receive one New Endo ordinary share. The number here represents shares of New Endo acquired pursuant to the Merger, of which 30,272 have been deferred under Endo Directors Deferred Compensation Plan.
- [F2]These restricted stock units granted on March 12, 2013 under the 2010 Stock Incentive Plan, of which none are vested as of February 28, 2014 with the unvested portion generally vesting 25% annually at each future grant date anniversary through March 12, 2017, were assumed by New Endo in the Merger and converted into New Endo restricted stock units with the same terms and conditions as the original Endo restricted stock units.
- [F3]These non-qualified stock options granted on June 26, 2008 under the 2004 Stock Incentive Plan, which were already fully vested as of February 28, 2014, were assumed by New Endo in the Merger and converted into options to purchase ordinary shares of New Endo for the listed exercise price per share with the same terms and conditions as the original Endo stock options.
- [F4]These non-qualified stock options granted on March 12, 2009 under the 2007 Stock Incentive Plan, which were already fully vested as of February 28, 2014, were assumed by New Endo in the Merger and converted into options to purchase ordinary shares of New Endo for the listed exercise price per share with the same terms and conditions as the original Endo stock options.
- [F5]These non-qualified stock options granted on March 12, 2010 under the 2007 Stock Incentive Plan, of which 6,071 were already vested as of February 28, 2014 with the unvested portion generally vesting 25% per year on each remaining grant date anniversary through March 12, 2014, were assumed by New Endo in the Merger and converted into options to purchase ordinary shares of New Endo for the listed exercise price per share with the same terms and conditions as the original Endo stock options.
Issuer
Endo International plc
CIK 0001593034
Entity typeoperating
Related Parties
1- filerCIK 0001593034
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 7:28 PM ET
- Size
- 20.0 KB